Although drug-eluting stents are increasingly used to treat coronary disease, restenosis remains the major limitation of these devices. We report a case of complete metal jacket using 17 stents for triple-vessel coronary disease in a 73-year-old man, for whom surgery would have been the best choice.
KoENasuKHabaraM. Long-term serial angiographic outcomes after sirolimus-eluting stent implantation. Catheter Cardiovasc Interv2013; 81: E29–E35.
2.
YusufSZuckerDPassamaniE. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet1994; 344: 563–570.
3.
HannanELRaczMJWalfordG. Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med2005; 352: 2174–2183.
4.
PrazLCookSMeierB. Percutaneous coronary interventions in Europe in 2005. EuroIntervention2008; 3: 442–446.
5.
MulukutlaSRVlachosHAMarroquinOC. Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung and Blood Institute Dynamic Registry. JACC Cardiovasc Interv2008; 1: 139–147.
6.
BabapulleMNJosephLBelislePBrophyJMEisenbergMJ. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet2004; 364: 583–591.
7.
SmithSCFeldmanTEHirshfeldJW. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol2006; 47: e1–e121.
